FAS and Alzheimer disease: In conclusion, our data show that loss of Fas activity strongly affects the early development of AD by leading to Th2-dominant inflammation characterized by dermal infiltration of CD4+ T cells, neutrophils and increased skin expression of Th2 cytokines.